Transplant center directory

Established in 2020 Orlando Health Cancer Institute’s Bone Marrow Transplant & Cellular Therapy program is part of the state-of-the-art, 10-story Charles Lewis Pavilion on the downtown Orlando campus. The program provides cellular therapy and stem cell transplantation for patients with conditions such as leukemia, lymphoma, multiple myeloma, bone marrow failures, and aplastic anemias. We offer autologous as well as allogeneic transplantation using all donor sources being matched siblings, unrelated donors, and alternative sources such as haploidentical and cord blood. The program offers inpatient and ambulatory services. Our institution obtained FACT accreditation February 1, 2023.

This center has been performing allogeneic transplants since 2021 and has been an NMDP/Be The Match transplant center since April 2022.

This center's actual 1-year survival results are above the expected rate for this center.

The survival information we have for this center includes ONLY:

1. Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2019, 2020, 2021, and
2. Who had their transplant at a U.S. transplant center, and
3. Who had follow-up information provided by the transplant center for analysis

For this center, we have survival information for 20 patients.

The actual 1-year survival of these patients is 80.0%.

Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 38.6% and 78.3%.

For help with understanding these statistics, please see Understanding Transplant Outcomes.

For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report at bloodcell.transplant.hrsa.gov.

All diseases

Number of transplants by age reported from January 1, 2021 to December 31st, 2022 (includes marrow, PBSC and cord blood)

Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.